Additionally, we have recently demonstrated that an exogenously administered GILZ protein can control the permeability of the gut in a mouse model of colitis [9], and that GILZ may act as a secretory protein, being expressed by goblet cells in human specimens [10]. This evidence concerns the gene TSC22D3 and colitis.